HCV RNA
Different Hepatitis C Virus (HCV) RNA Load Profiles Following Seroconversion among Injecting Drug Users without Correlation with HCV Genotype and Serum Alanine Aminotransferase Levels
6
Comparison of a Newly Developed Automated and Quantitative Hepatitis C Virus (HCV) Core Antigen Test with the HCV RNA Assay for Clinical Usefulness in Confirming Anti HCV Results
5
Qualitative Detection of Hepatitis C Virus RNA: Comparison of Analytical Sensitivity, Clinical Performance, and Workflow of the Cobas Amplicor HCV Test Version 2 0 and the HCV RNA Transcription Mediated Amplification Qualitative Assay
5
Comparison of Serum Hepatitis C Virus (HCV) RNA and Core Antigen Levels in Patients Coinfected with Human Immunodeficiency Virus and HCV and Treated with Interferon plus Ribavirin
6
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched DNA technology
7
Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription Mediated Amplification
8
Alanine aminotransferase, HCV RNA levels and pro inflammatory and pro fibrogenic cytokines/chemokines during acute hepatitis C virus infection
10
Impact of Hepatitis C Virus (HCV) Genotypes on Quantification of HCV RNA in Serum by COBAS AmpliPrep/COBAS TaqMan HCV Test, Abbott Antiretroviral Therapy HCV RealTime Assay, and VERSANT HCV RNA Assay
6
Stimulation of Hepatitis C Virus (HCV) Nonstructural Protein 3 (NS3) Helicase Activity by the NS3 Protease Domain and by HCV RNA-Dependent RNA Polymerase
11
HCV core antigen and HCV RNA in HIV/HCV co infected patients with different HCV genotypes
9
Comparative Evaluation of the VERSANT HCV RNA 3 0, QUANTIPLEX HCV RNA 2 0, and COBAS AMPLICOR HCV MONITOR Version 2 0 Assays for Quantification of Hepatitis C Virus RNA in Serum
7
Comparison of Qualitative (COBAS AMPLICOR HCV 2 0 versus VERSANT HCV RNA) and Quantitative (COBAS AMPLICOR HCV Monitor 2 0 versus VERSANT HCV RNA 3 0) Assays for Hepatitis C Virus (HCV) RNA Detection and Quantification: Impact on Diagnosis and Treatment of HCV Infections
8
The Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 2 0, Real Time PCR Assay Accurately Quantifies Hepatitis C Virus Genotype 4 RNA
5
Development and clinical validation of the Genedrive point of care test for qualitative detection of hepatitis C virus
8
Comparison of Conventional PCR with Real Time PCR and Branched DNA Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5
9
Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms
9
Effectiveness of HCV core antigen and RNA quantification in HCV infected and HCV/HIV 1 coinfected patients
8
Hepatitis C treatment initiation in HIV HCV coinfected patients
9
Most common HCV genotypes in patients from north-eastern Croatia
9
JBC-2005-Huang-36417-28.pdf
13